|
Volumn 34, Issue 3, 2002, Pages 745-747
|
Addition of an IL-15 mutant/FCγ2A antagonist protein protects islet allografts from rejection overriding costimulation blockade
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD8 ANTIGEN;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
FAS LIGAND;
GLUCOSE;
GRANZYME B;
INTERLEUKIN 15;
MUTANT PROTEIN;
PERFORIN;
STREPTOZOCIN;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ARTICLE;
CONTROLLED STUDY;
DENSITOMETRY;
DRUG MECHANISM;
GENE EXPRESSION;
GLUCOSE BLOOD LEVEL;
GRAFT REJECTION;
GRAFT SURVIVAL;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTE PROLIFERATION;
MOUSE;
NONHUMAN;
PANCREAS ISLET TRANSPLANTATION;
PRIORITY JOURNAL;
STREPTOZOCIN DIABETES;
ANIMALS;
ANTIGENS, CD;
ANTIGENS, DIFFERENTIATION;
GRAFT REJECTION;
HUMANS;
IMMUNOCONJUGATES;
IMMUNOGLOBULIN FC FRAGMENTS;
IMMUNOSUPPRESSIVE AGENTS;
INTERLEUKIN-15;
ISLETS OF LANGERHANS TRANSPLANTATION;
MICE;
MICE, INBRED BALB C;
MICE, INBRED C57BL;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
TRANSCRIPTION, GENETIC;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0036266012
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02900-1 Document Type: Article |
Times cited : (11)
|
References (19)
|